Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant
- PMID: 12070343
- PMCID: PMC124318
- DOI: 10.1073/pnas.122061399
Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant
Abstract
Ebselen [2-phenyl-1,2-benzisoselenazol-3(2H)-one], a seleno-organic compound with glutathione peroxidase-like activity is used in clinical trials against stroke. Human and bovine TrxR catalyzed the reduction of ebselen to ebselen selenol by NADPH with an apparent K(M)-value of 2.5 microM and a kcat of 588 min(-1). The addition of thioredoxin (Trx) stimulated the TrxR-catalyzed reduction of ebselen several-fold. This result was caused by a very fast oxidation of reduced Trx by ebselen with a rate constant in excess of 2 x 10(7) M(-1) s(-1). This rate is orders of magnitude faster than the reaction of dithiol Trx with insulin disulfides. Ebselen competed with disulfide substrates for reduction by Trx and, therefore, acted as an inhibitor of protein disulfide reduction by the Trx system. The inherent H2O2 reductase activity of mammalian TrxR dependent on its active-site selenocysteine residue was stimulated 10-fold by 2 microM ebselen and 25-fold in the additional presence of 5 microM Trx. Furthermore, the apparent K(M)-value of TrxR for H2O2 was lowered 25-fold to about 100 microM. Our results demonstrate that ebselen is a TrxR peroxidase which, in the presence of Trx, acted as a mimic of a peroxiredoxin. The activity with TrxR and oxidation of reduced Trx offer mechanistic explanations for the in vivo effects of ebselen as an antioxidant and anti-inflammatory agent. Our results demonstrate that the mechanism of action of ebselen may be predominantly via the Trx system rather than via glutathione.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613002.gif)
![Scheme 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s1.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq1220613008.gif)
![Scheme 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s2.gif)
![Scheme 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s3.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s4.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s5.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s6.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/124318/bin/pq12206130s7.gif)
Similar articles
-
Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.Free Radic Biol Med. 2018 Nov 1;127:238-247. doi: 10.1016/j.freeradbiomed.2018.05.081. Epub 2018 May 25. Free Radic Biol Med. 2018. PMID: 29807162 Review.
-
Diphenyl diselenide and analogs are substrates of cerebral rat thioredoxin reductase: a pathway for their neuroprotective effects.Neurosci Lett. 2011 Sep 26;503(1):1-5. doi: 10.1016/j.neulet.2011.07.050. Epub 2011 Aug 4. Neurosci Lett. 2011. PMID: 21839146
-
Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction.Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):103-9. doi: 10.1016/j.taap.2005.02.022. Toxicol Appl Pharmacol. 2005. PMID: 15979675 Review.
-
Ebselen is a dehydroascorbate reductase mimic, facilitating the recycling of ascorbate via mammalian thioredoxin systems.Antioxid Redox Signal. 2004 Feb;6(1):99-104. doi: 10.1089/152308604771978390. Antioxid Redox Signal. 2004. PMID: 14713340
-
A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase.J Biol Chem. 2002 Oct 18;277(42):39456-62. doi: 10.1074/jbc.M206452200. Epub 2002 Aug 12. J Biol Chem. 2002. PMID: 12177067
Cited by
-
Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H2O2, and triggers early onset mitochondrial dysfunction during adipogenesis of human liposarcoma SW872 cells.Redox Biol. 2023 Nov;67:102915. doi: 10.1016/j.redox.2023.102915. Epub 2023 Oct 12. Redox Biol. 2023. PMID: 37866162 Free PMC article.
-
Ebselen Inhibits the Growth of Lung Cancer Cells via Cell Cycle Arrest and Cell Death Accompanied by Glutathione Depletion.Molecules. 2023 Sep 6;28(18):6472. doi: 10.3390/molecules28186472. Molecules. 2023. PMID: 37764247 Free PMC article.
-
Should ebselen be considered for the treatment of mercury intoxication? A minireview.Toxicol Mech Methods. 2024 Jan;34(1):1-12. doi: 10.1080/15376516.2023.2258958. Epub 2024 Jan 1. Toxicol Mech Methods. 2024. PMID: 37731353 Free PMC article. Review.
-
Oxidative Stress in Healthy and Pathological Red Blood Cells.Biomolecules. 2023 Aug 18;13(8):1262. doi: 10.3390/biom13081262. Biomolecules. 2023. PMID: 37627327 Free PMC article. Review.
-
Evolutionarily Conserved Role of Thioredoxin Systems in Determining Longevity.Antioxidants (Basel). 2023 Apr 17;12(4):944. doi: 10.3390/antiox12040944. Antioxidants (Basel). 2023. PMID: 37107319 Free PMC article. Review.
References
-
- Muller A, Cadenas E, Graf P, Sies H. Biochem Pharmacol. 1984;33:3235–3239. - PubMed
-
- Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R. Biochem Pharmacol. 1984;33:3241–3245. - PubMed
-
- Muller A, Gabriel H, Sies H, Terlinden R, Fischer H, Romer A. Biochem Pharmacol. 1988;37:1103–1109. - PubMed
-
- Maiorino M, Roveri A, Coassin M, Ursini F. Biochem Pharmacol. 1988;37:2267–2271. - PubMed
-
- Schewe T. Gen Pharmacol. 1995;26:1153–1169. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous